Compound Detail
CHEMBL4764415
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cccc2[nH]c(C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C(=O)CO)cc12
Basic Information
| ChEMBL ID | CHEMBL4764415 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FTJJLHJSQOEVCN-YYWHXJBOSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
506.6
MW (Da)
1.09
ALogP
6
HBA
5
HBD
149.6
PSA (Ų)
0.26
QED
1
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.33
IC50 1 meas. best 6.99
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 103.0 | nM | 6.99 | Reversible inhibition of SARS coronavirus Urbani 3CL protease(9985 to 10902) usi... | 33054210 |
| SARS-CoV | EC50 | = | 47000.0 | nM | 4.33 | Antiviral activity against SARS COV-1 infected in monkey vero 76 cells assessed ... | 33054210 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33054210 | 10.1021/acs.jmedchem.0c01063 | SARS-CoV | 1 |
| 33054210 | 10.1021/acs.jmedchem.0c01063 | Unchecked | 1 |
| 33054210 | 10.1021/acs.jmedchem.0c01063 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine